XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Total Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
March 31,
20242023
(In thousands)
Stock option expense$3,509 $3,584 
Restricted stock expense4,797 5,040 
Performance restricted stock unit expense635 1,655 
Total pre-tax expense$8,941 $10,279 
Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Three Months Ended
March 31, 2024
Year Ended December 31, 2023
Expected volatility28.2 %26.0 %
Expected term (years)5.05.0
Risk-free interest rate4.31 %3.54 %
Expected dividend yield0.62 %0.72 %
Black-Scholes-Merton fair value per stock option granted$56.42 $38.11 
Summary of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20232,741 $101.20 
Granted231 181.93 
Exercised(321)79.67 
Forfeited(8)139.23 
Outstanding at March 31, 20242,643 $110.77 6.9$190.7 
Exercisable at March 31, 20241,962 $96.35 6.1$169.8 
Summary of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2023296 $135.39 
Granted144 181.93 
Vested(135)132.65 
Forfeited(3)139.47 
Non-vested restricted stock outstanding at March 31, 2024302 $158.83 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2023239 $131.90 
Granted77 181.93 
Performance assumption change 1
24 121.91 
Vested(99)121.91 
Forfeited  
Non-vested performance restricted stock outstanding at March 31, 2024241 $151.05 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.